Psyence Biomedical Ltd.
PBM
$0.5211
-$0.0122-2.29%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 219.37% | -45.05% | -45.05% | -45.05% | -- |
| Total Receivables | 565.43% | -- | -72.09% | -72.09% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 907.74% | -- | 317.77% | 317.77% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -- | 0.00% | 0.00% | -- |
| Total Current Assets | 235.34% | -- | -29.15% | -29.15% | -- |
|
|
|||||
| Total Current Assets | 235.34% | -- | -29.15% | -29.15% | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 236.85% | -- | -28.81% | -28.81% | -- |
|
|
|||||
| Total Accounts Payable | -11.91% | -- | -65.46% | -65.46% | -- |
| Total Accrued Expenses | -- | -- | -22.51% | -22.51% | -- |
| Short-term Debt | 76.64% | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 112.50% | -- | 575.98% | 575.98% | -- |
|
|
|||||
| Total Current Liabilities | 112.50% | -- | 575.98% | 575.98% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 76.64% | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 112.50% | -- | 575.98% | 575.98% | -- |
|
|
|||||
| Common Stock & APIC | 5,490.56% | -- | 677.29% | 677.29% | -- |
| Retained Earnings | -- | -- | -812.06% | -812.06% | -- |
| Treasury Stock & Other | -- | -- | 118.32% | 118.32% | -- |
| Total Common Equity | -27.80% | -5,375.30% | -5,375.30% | -5,375.30% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -27.80% | -5,375.30% | -5,375.30% | -5,375.30% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -27.80% | -5,375.30% | -5,375.30% | -5,375.30% | -- |
|
|
|||||